{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:00:36Z","timestamp":1777489236991,"version":"3.51.4"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-024-01768-1","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T09:02:01Z","timestamp":1712307721000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Letter to the editor on: prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume"],"prefix":"10.1186","volume":"12","author":[{"given":"Cinzia","family":"Bocca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Kouassi-Nzoughet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Manuel","family":"Chao de la Barca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Bonneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Verny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Gohier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Orssaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0802-4608","authenticated-orcid":false,"given":"Pascal","family":"Reynier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,5]]},"reference":[{"issue":"1","key":"1768_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40478-024-01724-z","volume":"12","author":"A Otmani","year":"2024","unstructured":"Otmani A, J\u00f3hannesson G, Brautaset R, Tribble JR, Williams PA (2024) Prophylactic nicotinamide treatment protects from rotenone-induced neurodegeneration by increasing mitochondrial content and volume. Acta Neuropathol Commun 12(1):37. https:\/\/doi.org\/10.1186\/s40478-024-01724-z","journal-title":"Acta Neuropathol Commun"},{"issue":"6326","key":"1768_CR2","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1126\/science.aal0092","volume":"355","author":"PA Williams","year":"2017","unstructured":"Williams PA, Harder JM, Foxworth NE, Cochran KE, Philip VM, Porciatti V et al (2017) Vitamin B3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Science 355(6326):756\u2013760. https:\/\/doi.org\/10.1126\/science.aal0092","journal-title":"Science"},{"issue":"7","key":"1768_CR3","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/ceo.13818","volume":"48","author":"F Hui","year":"2020","unstructured":"Hui F, Tang J, Williams PA, McGuinness MB, Hadoux X, Casson RJ et al (2020) Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3) supplementation: a crossover randomized clinical trial. Clin Exp Ophthalmol 48(7):903\u2013914. https:\/\/doi.org\/10.1111\/ceo.13818","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"1768_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1001\/jamaophthalmol.2021.4576","volume":"140","author":"CG De Moraes","year":"2022","unstructured":"De Moraes CG, John SWM, Williams PA, Blumberg DM, Cioffi GA, Liebmann JM (2022) Nicotinamide and pyruvate for Neuroenhancement in Open-AngleGlaucoma: a phase 2 Randomized Clinical Trial. JAMA Ophthalmol 140(1):11\u201318. https:\/\/doi.org\/10.1001\/jamaophthalmol.2021.4576","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"1768_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/hmg\/ddab013","volume":"30","author":"C Bocca","year":"2021","unstructured":"Bocca C, Le Paih V, Chao de la Barca JM, Kouassy Nzoughet J, Amati-Bonneau P, Blanchet O et al (2021) A plasma metabolomic signature of Leber hereditary optic neuropathy showing taurine and nicotinamide deficiencies. Hum Mol Genet 30(1):21\u201329. https:\/\/doi.org\/10.1093\/hmg\/ddab013","journal-title":"Hum Mol Genet"},{"issue":"1","key":"1768_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1167\/iovs.17-23027","volume":"59","author":"C Bocca","year":"2018","unstructured":"Bocca C, Kouassi Nzoughet J, Leruez S, Amati-Bonneau P, Ferr\u00e9 M, Kane MS et al (2018) A plasma metabolomic signature Involving Purine Metabolism in Human Optic Atrophy 1 (OPA1)-Related disorders. Invest Ophthalmol Vis Sci 59(1):185\u2013195. https:\/\/doi.org\/10.1167\/iovs.17-23027","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"1768_CR7","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1167\/iovs.19-27099","volume":"60","author":"J Kouassi Nzoughet","year":"2019","unstructured":"Kouassi Nzoughet J, de la Chao JM, Guehlouz K, Leruez S, Coulbault L, Allouche S et al (2019) Nicotinamide Deficiency in Primary Open-Angle Glaucoma. Invest Ophthalmol Vis Sci 60(7):2509\u20132514. https:\/\/doi.org\/10.1167\/iovs.19-27099","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-024-01768-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-024-01768-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-024-01768-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T09:04:17Z","timestamp":1712307857000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-024-01768-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,5]]},"references-count":7,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1768"],"URL":"https:\/\/doi.org\/10.1186\/s40478-024-01768-1","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,5]]},"assertion":[{"value":"18 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies discussed in this letter have been performed in accordance with the Declaration of Helsinki. They were approved by the Ethical Committee of the University Hospital of Angers (<i>Comit\u00e9 de Protection des Personnes CPP Ouest II<\/i>, Angers, France; identification number: CPP CB 2014\/02; declaration number: DC-2011-1467; authorization number: AC-2017-2993). All participants provided a written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The participants have provided consent for publication of data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no financial and non-financial competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}